MegaPro Biomedical Co (ROCO:6827) EPS (Basic) : NT$-2.68 (TTM As of Dec. 2024)

View and export this data going back to 2021. Start your Free Trial

What is MegaPro Biomedical Co EPS (Basic)?

MegaPro Biomedical Co's basic earnings per share (Basic EPS) for the six months ended in Dec. 2024 was NT$-1.39. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Dec. 2024 was NT$-2.68.

MegaPro Biomedical Co's EPS (Diluted) for the six months ended in Dec. 2024 was NT$-1.39. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Dec. 2024 was NT$-2.68.

MegaPro Biomedical Co's EPS without NRI for the six months ended in Dec. 2024 was NT$-1.39. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Dec. 2024 was -2.68.

During the past 3 years, the average EPS without NRI Growth Rate was -17.50% per year. During the past 5 years, the average EPS without NRI Growth Rate was 5.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 7 years, MegaPro Biomedical Co's highest 3-Year average EPS without NRI Growth Rate was 21.70% per year. The lowest was -17.50% per year. And the median was 12.40% per year.

MegaPro Biomedical Co EPS (Basic) Historical Data

The historical data trend for MegaPro Biomedical Co's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

MegaPro Biomedical Co EPS (Basic) Chart

MegaPro Biomedical Co Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

EPS (Basic)

Get a 7-Day Free Trial

-2.90

-1.65

-2.02

-2.30

-2.68

MegaPro Biomedical Co Semi-Annual Data
	Dec18	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
EPS (Basic)	Get a 7-Day Free Trial							-0.96	-1.13	-1.17	-1.29	-1.39

MegaPro Biomedical Co EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

MegaPro Biomedical Co's Basic EPS for the fiscal year that ended in Dec. 2024 is calculated as

Basic EPS (A: Dec. 2024 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(-164.041	-	0)	/	61.298
	=	-2.68

MegaPro Biomedical Co's Basic EPS for the quarter that ended in Dec. 2024 is calculated as

Basic EPS (Q: Dec. 2024 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(-86.807	-	0)	/	62.914
	=	-1.38

EPS (Basic) for the trailing twelve months (TTM) ended in Dec. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was NT$-2.68

MegaPro Biomedical Co (ROCO:6827) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

MegaPro Biomedical Co EPS (Basic) Related Terms

Thank you for viewing the detailed overview of MegaPro Biomedical Co's EPS (Basic) provided by GuruFocus.com. Please click on the following links to see related term pages.

MegaPro Biomedical Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » MegaPro Biomedical Co Ltd (ROCO:6827) » Definitions » EPS (Basic)

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 66, Shengyi 5th Road, 10F-1, Hsinchu Science Park, Hsinchu, TWN, 31040

Website

https://www.megaprobio.com

MegaPro Biomedical Co Ltd is a nanomedicine development company. The Company's only reportable operating segment is the Drug Application Development segment, which is engaged in the development of nano-iron oxide IOP drugs.

MegaPro Biomedical Co Headlines

No Headlines